Alnylam Pharmaceuticals Inc (ALNY)

264.47 -4.48 (-1.67%) USD  |  NASDAQ  |  Nov 13, 16:00
265.29 +0.82 (+0.31%) After-Hours: 20:00
More

Alnylam Pharmaceuticals Net Preferred Equity Issued (Purchased) (Quarterly)

Net Preferred Equity Issued (Purchased) (Quarterly) Chart

View Net Preferred Equity Issued (Purchased) (Quarterly) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Net Preferred Equity Issued (Purchased) (Quarterly) Data

View and export this data back to . Upgrade now.
Date Value

Net Preferred Equity Issued (Purchased) (Quarterly) Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

Net Preferred Equity Issued (Purchased) (Quarterly) Benchmarks

Pfizer Inc --
BridgeBio Pharma Inc --
Biomarin Pharmaceutical Inc --
Gilead Sciences Inc --
Regeneron Pharmaceuticals Inc --